Next six months will be very interesting.
Balance between "guts" to hang in there versus reality is always the equation with any spec stock - especially in the biotech sector.
BIT does need some commercial deal to e in place that will lift the SP. Personally, I am concerned that the COVID results will not deliver the necessary impetus to make that happen - BUT anything is still possible.
BIT will be very fortunate if they can get the ffunds from the options - and they will have the R&D if, as MM has indicated, early as well.
No commercial deal and no funds from the options will make things much more complicated.
One thing of worry is that BIT does not seem to have any firm direction at the moment - cancer, antiviral, HepC, HIV - where are they headed? They need some focus.
Next six months will be very interesting.Balance between "guts"...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.002(7.14%) |
Mkt cap ! $23.46M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.6¢ | $51.84K | 1.992M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 198646 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 199924 | 1 |
View Market Depth
| Last trade - 15.36pm 30/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |